High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00417690
Recruitment Status : Terminated (Efforts at recruitment have halted as recruitment was poor.)
First Posted : January 4, 2007
Last Update Posted : October 15, 2008
Information provided by:
Jacobus Pharmaceutical

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2007
  Actual Study Completion Date : October 2008